VOYA Investment Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.15M | Sell |
142,597
-661,540
| -82% | -$11.6M | ﹤0.01% | 1206 |
|
|
2026
Q1 | $15.4M | Buy |
804,137
+484,609
| +152% | +$10.5M | 0.02% | 513 |
|
|
2025
Q4 | $7.02M | Buy |
319,528
+145,382
| +83% | +$2.62M | 0.01% | 748 |
|
|
2025
Q3 | $2.11M | Buy |
174,146
+36,397
| +26% | +$493K | ﹤0.01% | 1208 |
|
|
2025
Q2 | $2.57M | Buy |
137,749
+1,051
| +0.8% | +$20.8K | ﹤0.01% | 1197 |
|
|
2025
Q1 | $2.62M | Buy |
136,698
+38,519
| +39% | +$1.13M | ﹤0.01% | 1198 |
|
|
2024
Q4 | $3.54M | Buy |
98,179
+68,599
| +232% | +$2.32M | ﹤0.01% | 1085 |
|
|
2024
Q3 | $1.25M | Sell |
29,580
-613
| -2% | -$26K | ﹤0.01% | 1521 |
|
|
2024
Q2 | $1.22M | Buy |
30,193
+11,112
| +58% | +$464K | ﹤0.01% | 1522 |
|
|
2024
Q1 | $676K | Sell |
19,081
-478
| -2% | -$12.8K | ﹤0.01% | 1851 |
|
|
2023
Q4 | $579K | Sell |
19,559
-1,703
| -8% | -$35.3K | ﹤0.01% | 1996 |
|
|
2023
Q3 | $442K | Sell |
21,262
-6,526
| -23% | -$179K | ﹤0.01% | 2104 |
|
|
2023
Q2 | $682K | Sell |
27,788
-31,466
| -53% | -$1.01M | ﹤0.01% | 1902 |
|
|
2023
Q1 | $2.41M | Sell |
59,254
-14,121
| -19% | -$585K | ﹤0.01% | 1278 |
|
|
2022
Q4 | $3.3M | Sell |
73,375
-48,977
| -40% | -$2.22M | ﹤0.01% | 1135 |
|
|
2022
Q3 | $5.85M | Sell |
122,352
-399,379
| -77% | -$21.9M | 0.01% | 889 |
|
|
2022
Q2 | $30.9M | Buy |
521,731
+4,529
| +0.9% | +$372K | 0.08% | 223 |
|
|
2022
Q1 | $60.1M | Buy |
517,202
+157,768
| +44% | +$18.4M | 0.12% | 156 |
|
|
2021
Q4 | $54.1M | Sell |
359,434
-90,355
| -20% | -$12.2M | 0.1% | 179 |
|
|
2021
Q3 | $53.7M | Sell |
449,789
-12,870
| -3% | -$1.42M | 0.11% | 179 |
|
|
2021
Q2 | $45.1M | Sell |
462,659
-725,287
| -61% | -$64.7M | 0.09% | 209 |
|
|
2021
Q1 | $105M | Sell |
1,187,946
-167,300
| -12% | -$15.5M | 0.21% | 109 |
|
|
2020
Q4 | $130M | Buy |
1,355,246
+304,590
| +29% | +$31.4M | 0.26% | 94 |
|
|
2020
Q3 | $119M | Buy |
1,050,656
+572,125
| +120% | +$60.1M | 0.26% | 93 |
|
|
2020
Q2 | $47.3M | Buy |
478,531
+37,563
| +9% | +$3M | 0.11% | 185 |
|
|
2020
Q1 | $28.4M | Sell |
440,968
-123,369
| -22% | -$8.64M | 0.08% | 228 |
|
|
2019
Q4 | $33.6M | Sell |
564,337
-9,700
| -2% | -$598K | 0.07% | 249 |
|
|
2019
Q3 | $33.9M | Buy |
574,037
+28,458
| +5% | +$1.82M | 0.07% | 254 |
|
|
2019
Q2 | $35.2M | Buy |
545,579
+407,444
| +295% | +$26.3M | 0.08% | 243 |
|
|
2019
Q1 | $8.77M | Sell |
138,135
-14,479
| -9% | -$761K | 0.02% | 623 |
|
|
2018
Q4 | $5.79M | Buy |
152,614
+132,710
| +667% | +$4.69M | 0.01% | 705 |
|
|
2018
Q3 | $853K | Buy |
19,904
+2,362
| +13% | +$82.5K | ﹤0.01% | 1501 |
|
|
2018
Q2 | $386K | Buy |
+17,542
| New | +$216K | ﹤0.01% | 1987 |
|
Other funds holding TNDM
SC
FLAM
GKIM
PIM
VOYA Investment Management's TNDM Position: Q2 2026 in Review
VOYA Investment Management reduced its Tandem Diabetes Care (TNDM) stake by 82% in Q2 2026, selling an estimated $11.6M and leaving 142,597 shares worth $2.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1206.
VOYA Investment Management first reported a position in TNDM in Q2 2018 and has held it in 33 quarters since. The position peaked at $130M in Q4 2020. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- VOYA Investment Management held 142,597 shares of Tandem Diabetes Care worth $2.15M as of Q2 2026.
- VOYA Investment Management sold 661,540 Tandem Diabetes Care shares in Q2 2026, an estimated $11.6M.
- Tandem Diabetes Care made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1206 holding.
- VOYA Investment Management first reported a position in Tandem Diabetes Care in Q2 2018 and has held it in 33 quarters since.
- VOYA Investment Management's Tandem Diabetes Care position peaked at $130M in Q4 2020.
- 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.